Company · Liverpool Liquidation
Glaxosmithkline US Trading Limited
Wholesale of pharmaceutical goods
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Glaxosmithkline US Trading Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 10
- Andrew James Collier 2025-2025 View profile
- Neil Richard Wilkinson 2024-2025 View profile
- Gabriel Millan 2023-2024 View profile
- Dr Yvonne Margaret Stewart 2021-2025 View profile
- Wendy Adams 2021-2024 View profile
- Benoit Marie Alsteens 2020-2021 View profile
- Jay Wade Green 2018-2020 View profile
- Jonathan Box 2018-2023 View profile
- Adam Walker 2018-2020 View profile
- Mark James Heathcote 2018-2025 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Wholesale of pharmaceutical goods
- Incorporated
- 12/09/2018
- Registered office
- Liverpool
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Glaxo Group Limited
75-100% shares, 75-100% voting, appoints directors · notified 2018-09-12
Group
- Glaxosmithkline US Trading Limited
is controlled by Glaxo Group Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2018-09-12 · source: Companies House PSC register - Glaxo Group Limited
is controlled by Glaxosmithkline Finance PLC
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Glaxosmithkline Finance PLC
is controlled by Glaxosmithkline Holdings Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register - Glaxosmithkline Holdings Limited
is controlled by GSK PLC
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by GSK PLC.
86 other companies in this group
- Smithkline Beecham Legacy H Limited
- Smithkline Beecham Overseas Limited
- GSK LP Limited
- Setfirst Holdings Limited
- Stevenage Bioscience Catalyst
- Glaxo Laboratories Limited
- Smithkline Beecham Senior Executive Pension Plan Trustee Limited
- Glaxosmithkline IHC Limited
- Smithkline Beecham Marketing and Technical Services Limited
- Stiefel Laboratories (Maidenhead) Limited
- GSK Equity Investments NO2 Limited
- Viiv Healthcare Finance Limited
- Charles Midgley Limited
- GSK Finance (NO 2) Limited
- Glaxosmithkline Caribbean Limited
- Burroughs Wellcome International Limited
- Smithkline Beecham Pension Trustees Limited
- Stiefel Laboratories Limited
- Glaxosmithkline Mercury Limited
- Setfirst Limited
- Dealcyber Limited
- GSK Finance (NO.3) Limited
- Viiv Healthcare UK (NO.5) Limited
- Viiv Healthcare Finance 2 Limited
- Wellcome Consumer Healthcare Limited
- Glaxo Wellcome UK Limited
- Glaxosmithkline Intellectual Property Management Limited
- Glaxosmithkline Intellectual Property Limited
- Mixis Genetics Limited
- Glaxo Group Limited
- Allen & Hanburys Limited
- Glaxosmithkline Intellectual Property Holdings Limited
- Smithkline Beecham (Export) Limited
- Glaxosmithkline Intellectual Property Development Limited
- Viiv Healthcare Trading Services UK Limited
- Viiv Healthcare Finance 1 Limited
- Clarges Pharmaceuticals Limited
- Glaxo Trustees Limited
- Glaxosmithkline International Limited
- Glaxochem (UK) Unlimited
- Viiv Healthcare Limited
- Tres Cantos Open LAB Foundation
- Viiv Healthcare UK (NO.3) Limited
- Glaxosmithkline Intellectual Property (NO.5) Limited
- Eskaylab Limited
- Glaxosmithkline Intellectual Property (NO.2) Limited
- Viiv Healthcare UK (NO.4) Limited
- Cellzome Limited
- Smithkline Beecham (SWG) Limited
- Smith Kline & French Laboratories Limited
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
1 directors on the board
- Aidan Lynch Director · appointed 2019
Directors past 6 years
- Aidan Lynch Director · appointed 2019
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Gaps to watch
- A single director - no second pair of eyes on any decision
Where to look Suggested search: a second director to remove single-point control.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 11566030
- Status
- Liquidation
- Type
- Private Limited Company
- Accounts next due
- 30/09/2026
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data